Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
PodcastOne (PODC) Unveils Explosive 10th Season of The Opportunist: "Tim Ballard: Unmasking a Hero" - Exposing Dark Allegations
-
ManTech Earns FinOps Foundation’s FinOps Service Provider Certification
-
Auburn National Bancorporation, Inc. Reports Third Quarter Net Earnings
-
Reflect Scientific Inc. Secures $225,000 Order for Cutting-Edge Freezer Systems
-
Fuel Tech Announces FUEL CHEM® Commercial Contract for a New Domestic Utility Customer
-
RTI Joins the Common Vulnerabilities and Exposures (CVE®) Program as a CVE Numbering Authority (CNA)
-
Twin Disc Announces Details of Fiscal 2025 First Quarter Earnings Release, Webcast, and Conference Call
-
Crowdbotics Speaking at GitHub Universe 2024 in San Francisco
-
Dominion Lending Centres Inc. Announces Third Quarter 2024 Earnings Release Date
-
Taysha Gene Therapies to Present Biodistribution Data from an Analysis Evaluating AAV9 Gene Therapy Delivery at the Upcoming 31st Annual ESGCT Congress
-
Big 5 Sporting Goods Corporation to Report Fiscal 2024 Third Quarter Results on October 29, 2024
-
Lexicon Announces Completion of Screening in Phase 2B Progress Study of LX9211 in Diabetic Peripheral Neuropathic Pain (DPNP)
-
The United States Air Force and the Drone Racing League Expand Talent Recruitment Efforts with their Inaugural Drone Racing Championship Event Taking Flight in 2025
-
MangoRx Announces Formation of Strategy and Alternatives Committee
-
The Assembly Canada by ACAMS to Unite 40+ Experts in ‘The Good Fight’ Against Financial Crime
-
BOS' Supply Chain Division Receives a $500,000 order from a Customer in India
-
Hibbett and Nike unveil new philanthropic initiative, First String, with $50,000 inaugural donation
-
Endexx Corporation’s HYLA Division Partners With American Shaman, Expanding Distribution Across U.S. Locations
-
Scorpius Holdings Announces Partnership with U.S. Biotech Company
-
MeiraGTx Announces Five Posters at the European Society of Gene and Cell Therapy (ESGCT) 2024 Annual Congress
-
FuelCell Energy and KHNP to Pursue Clean Hydrogen Production Projects in Korea
-
Asset Entities Inc. is Pleased to Announce that it has Received an Extension from Nasdaq to Regain Compliance with Nasdaq Listing Rule 5550(b)
-
WillScot Announces Appointment of Worthing Jackman to Board of Directors
-
American Medical Association Approves Groundbreaking New CPT Codes for Totally Implantable Active Middle Ear Hearing Implants Opening New Opportunities for Envoy Medical’s Esteem® Device
-
ProPhase Labs to Present at the 2024 ThinkEquity Conference
-
Westwood Holdings Group, Inc. to Host Third Quarter 2024 Conference Call/Webcast
-
Menlo Micro Announces Global Distribution Agreement with DigiKey to Promote and Deliver Ideal Switch® Products
-
Cayson Acquisition Corp Announces Separate Trading of its Ordinary Shares and Rights
-
Recursion announces first patient dosed in Phase 2 clinical study of REC-3964, a potential first-in-class, oral, non-antibiotic small molecule for recurrent Clostridioides difficile infection
-
Annovis to Highlight Buntanetap's Alzheimer's Research Progress with Presentations at CTAD 2024
-
ARMLOGI ENHANCES WAREHOUSE OPERATIONS WITH AI-INTEGRATED WAREHOUSE MANAGEMENT SYSTEM
-
XOMA Royalty Significantly Expands its Royalty and Milestone Portfolio with the Addition of Over 60 Early-Stage Programs from Twist Bioscience
-
Monopar Presents Encouraging Human Clinical Dosimetry Data on its uPAR Program at EANM 2024
-
Janover Unveils Janover Connect: A Reimagined Real Estate Syndication Platform
-
InnovAge to Announce Fiscal First Quarter 2025 Financial Results and Host Conference Call Tuesday, November 5, 2024
-
Gabelli Funds to Host 48th Annual Automotive Symposium at The Encore at Wynn, Las Vegas, Nevada
-
Indaptus Therapeutics Announces Clinical Supply Agreement with BeiGene to Evaluate Novel Cancer Treatment Combinations
-
PDS Biotech Announces Presentation of Rationale and Design of First Recurrent Prostate Cancer Trial to Combine an Androgen Receptor Pathway Inhibitor with an Immunocytokine
-
Huntress Recognized as Inc. 2024 Power Partner for Empowering Small and Mid-Sized Businesses with Cutting-Edge Cybersecurity Protection
-
Blade Air Mobility to Announce Third Quarter 2024 Financial Results on November 12, 2024
-
PodcastOne (PODC) Unveils Explosive 10th Season of The Opportunist: "Tim Ballard: Unmasking a Hero" - Exposing Dark Allegations
-
Guess What? Nobody and Everybody Cares About AI
-
Aligos Therapeutics Announces U.S. FDA Clearance of IND Application for ALG-000184
-
Nukkleus Announces Reverse Stock Split Shares Will Begin Trading on a Split-Adjusted Basis on October 24, 2024
-
Crunchtime Unveils AI Forecasting
-
Arteris to Announce Financial Results for the Third Quarter 2024 on Tuesday, November 5, 2024
-
Reminder: Program for the publication of Yara International ASA third quarter results 2024
-
Allarity Therapeutics to be Granted European Patent for DRP® Companion Diagnostic for Stenoparib
-
ThreatQuotient Unites Cybersecurity Leaders for a Week of In-Depth Threat Intelligence Exploration
-
ZyVersa Therapeutics Highlights Published Data Demonstrating That Obesity Results in Neuroinflammation Implicated in Development of Neurodegenerative Diseases
